Ricardo Costa

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabate M, Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Perez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions

Zimarino M, Angiolillo D, Dangas G, Capodanno D, Barbato E, Hahn J, Giustino G, Watanabe H, Costa F, Cuisset T, Rossini R, Sibbing D, Burzotta F, Louvard Y, Shehab A, Renda G, Kimura T, Gwon H, Chen S, Costa R, Koo B, Storey R, Valgimigli M, Mehran R, Stankovic G

May 16, 2021 | 10.4244/EIJ-D-20-00885

Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system

Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A

December 18, 2020 | 10.4244/EIJ-D-20-00763

Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions

Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamié D, Abizaid An, Boersma E, Abizaid A

October 18, 2019 | 10.4244/EIJ-D-18-00292

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S

December 7, 2018 | 10.4244/EIJ-D-18-00762

Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study

Lee WLS, Tam FCC, Chan KKW, Lam S, Kong S-L, Shea CP, Wong MKL, Wong AYT, Yung ASY, Zhang L-W, Lam Y-M, Mintz GS, Costa R, Stoll H, Maehara A

September 20, 2018 | 10.4244/EIJ-D-18-00061

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Seth A, Onuma Y, Costa R, Chandra P, Bahl V, Manjunath C, Mahajan A, Ajit Kumar V, Goel P, Wander G, Kalarickal M, Kaul U

July 20, 2017 | 10.4244/EIJ-D-17-00306

Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club

Collet C, Onuma Y, Cavalcante R, Grundeken M.J, Généreux P, Popma J, Costa R, Stankovic G, Tu S, Reiber J, Aben J, Lassen J, Louvard Y, Lansky A, Serruys P

May 15, 2017 | 10.4244/EIJ-D-16-00932

Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study

Collet C, Corral J, Cavalcante R, Tateishi H, Belzarez O, Costa J, Costa R, Chamié D, Onuma Y, de Winter R, Abizaid A, Serruys P

April 7, 2017 | 10.4244/EIJ-D-16-00868

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

IVUS in bifurcation stenting: what have we learned?

Legutko J, Yamawaki M, Costa R, Costa M

May 19, 2015 | 10.4244/EIJV11SVA12

The ABS mother-daughter platforms

Khorsandi M, Abizaid A, Dani S, Bourang H, Costa R, Kar S, Makkar R

May 19, 2015 | 10.4244/EIJV11SVA36

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

Dani S, Costa R, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A

August 23, 2013 | 10.4244/EIJV9I4A79

Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents

Costa Jr J, Abizaid A, Sousa A, Siqueira D, Chamié D, Feres F, Costa R, Staico R, Maldonado G, Centemero M, Tanajura L, Viana R, Chaves Á, Abizaid An, Sousa J

June 27, 2012 | 10.4244/EIJV8I2A36

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Costa R, Abizaid A, Abizaid An, García del Blanco B, Berland J, Petrov I, Brenot P, van Geuns R, Royer T, Rubino P, Lesiak M, Fajadet J

March 21, 2012 | 10.4244/EIJV7I11A205

Advanced Bifurcation Systems' mother-daughter platform

Khorsandi M, Abizaid A, Dani S, Bourang H, Costa R, Kar S, Makkar R

January 11, 2011

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice

Feres R, Andrade P, Costa R, Costa Jr J, Abizaid A, Staico R, Tanajura L, Siqueira D, Maia J, Lasave L, Sousa A, Sousa J

August 14, 2009

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

Costa Júnior J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Abizaid An, Tanajura L, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa A, Fitzgerald P, Sousa J

May 13, 2008

The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions

Costa R, Eduardo Sousa J, Abizaid A, Chaves A, Feres F, Sousa A, Musumeci G, Mehran R, Fitzgerald P, Lansky A, Leon MB, Shiran A, Halon D, Lewis B, Guagliumi G

November 20, 2006

Ricardo Costa

Latest news